Systemic Rho-kinase inhibitor belumosudil for treatment of ocular graft versus host disease. Gomez C, Martinez Guasch F, Jhanji V, Sunshine SB, et al. Br J Ophthalmol 2025 Oct 20:bjo-2025-327877. doi: 10.1136/bjo-2025-327877.

Read + Share

Amedeo Smart

Independent Medical Education

Gomez C, Martinez Guasch F, Jhanji V, Sunshine SB, et al. Systemic Rho-kinase inhibitor belumosudil for treatment of ocular graft versus host disease. Br J Ophthalmol 2025 Oct 20:bjo-2025-327877. doi: 10.1136/bjo-2025-327877.
PMID: 41115743